Filtered By:
Therapy: Neoadjuvant Therapy
This page shows you your search results in order of date. This is page number 11.
Order by Relevance | Date
Total 9957 results found since Jan 2013.
ASO Visual Abstract: Discordant Breast and Axillary Pathologic Response to Neoadjuvant Chemotherapy
Ann Surg Oncol. 2023 Aug 29. doi: 10.1245/s10434-023-14172-1. Online ahead of print.NO ABSTRACTPMID:37644246 | DOI:10.1245/s10434-023-14172-1
Source: Ann Oncol - August 29, 2023 Category: Cancer & Oncology Authors: Rene Flores Estefania Roldan Jaime A Pardo Leah Beight Jessalyn Ubellacker Betty Fan Roger B Davis Ted A James Source Type: research
Clinical implications of dose to functional lung volumes in the trimodality treatment of esophageal cancer
CONCLUSION: Small ALV and increasing FLV exposed to intermediate (10 to 20 Gy) dose are associated to postoperative pulmonary complications. Changes of DLCO occur during nCRT but do not seem to be related to radiation dose to ALV or FLV. This information could attribute towards toxicity risk prediction and reduction strategies for EC.PMID:37643135 | DOI:10.1080/0284186X.2023.2251091
Source: Acta Oncologica - August 29, 2023 Category: Cancer & Oncology Authors: Pieter Populaire Gilles Defraene Philippe Nafteux Lieven Depypere Johnny Moons Sofie Isebaert Karin Haustermans Source Type: research
Efficacy and safety of trastuzumab with or without a tyrosine kinase inhibitor for HER2-positive breast cancer: A systematic review and meta-analysis
CONCLUSIONS: Trastuzumab plus TKI was better than trastuzumab monotherapy for treating different stages of HER2-positive breast cancer. The safety of trastuzumab plus TKI anti-HER2 therapy was controllable. The different efficacies of TKIs combined with trastuzumab may be related to the mechanism of action of the different TKIs, needing further investigations.PMID:37640146 | DOI:10.1016/j.bbcan.2023.188969
Source: Biochimica et Biophysica Acta - August 28, 2023 Category: Biochemistry Authors: Lixi Li Di Zhang Yun Wu Jiayu Wang Fei Ma Source Type: research
ASO Visual Abstract: Exploration of Malignant Characteristics in Neoadjuvant Chemotherapy-Resistant Rectal Cancer, Focusing on Extramural Lesions
Ann Surg Oncol. 2023 Aug 29. doi: 10.1245/s10434-023-14107-w. Online ahead of print.NO ABSTRACTPMID:37640986 | DOI:10.1245/s10434-023-14107-w
Source: Ann Oncol - August 28, 2023 Category: Cancer & Oncology Authors: Shunsuke Kubota Takuya Miura Taiichi Wakiya Tadashi Yoshizawa Shintaro Goto Hajime Morohashi Yoshiyuki Sakamoto Yota Tatara Hiroshi Kijima Kenichi Hakamada Source Type: research
Efficacy and safety of trastuzumab with or without a tyrosine kinase inhibitor for HER2-positive breast cancer: A systematic review and meta-analysis
CONCLUSIONS: Trastuzumab plus TKI was better than trastuzumab monotherapy for treating different stages of HER2-positive breast cancer. The safety of trastuzumab plus TKI anti-HER2 therapy was controllable. The different efficacies of TKIs combined with trastuzumab may be related to the mechanism of action of the different TKIs, needing further investigations.PMID:37640146 | DOI:10.1016/j.bbcan.2023.188969
Source: Biochimica et Biophysica Acta - August 28, 2023 Category: Biochemistry Authors: Lixi Li Di Zhang Yun Wu Jiayu Wang Fei Ma Source Type: research
The Efficacy of Neoadjuvant Gemcitabine and Cisplatin Chemotherapy for cT3N0M0 Upper Tract Urothelial Carcinoma: The Impact of Tumor Location
CONCLUSION: NAC-GC improves both pathological outcomes and oncological prognosis in patients with cT3N0M0 UTUC. With regard to tumor location, RPT has better pathological outcomes and oncological prognoses than UT.PMID:37634073
Source: Urology Journal - August 27, 2023 Category: Urology & Nephrology Authors: Yuki Kohada Tetsutaro Hayashi Kenshiro Takemoto Syunsuke Miyamoto Takashi Babasaki Kohei Kobatake Hiroyuki Kitano Kenichiro Ikeda Keisuke Goto Keisuke Hieda Yukiko Honda Kazuhiro Sentani Naohide Oue Kazuo Awai Nobuyuki Hinata Source Type: research
Impact of warm saline irrigation, hyperthermic intraperitoneal chemotherapy on postoperative pain in primary ovarian cancer from the KOV-HIPEC-01 randomized trial
CONCLUSION: The addition of HIPEC to cytoreductive surgery did not lead to increased postoperative pain, as demonstrated by a reduction in the use of analgesics and lower scores on postoperative pain scales during the early postoperative period.PMID:37634257 | DOI:10.1016/j.ygyno.2023.08.006
Source: Gynecologic Oncology - August 27, 2023 Category: Cancer & Oncology Authors: Ji Hyun Kim Kyung Nam Park Eun Young Park Min Jung Jang Yoen Jung Park Youseok Kim Suk-Joon Chang Sang-Yoon Park Jung Yeon Yun Myong Cheol Lim Source Type: research
The Efficacy of Neoadjuvant Gemcitabine and Cisplatin Chemotherapy for cT3N0M0 Upper Tract Urothelial Carcinoma: The Impact of Tumor Location
CONCLUSION: NAC-GC improves both pathological outcomes and oncological prognosis in patients with cT3N0M0 UTUC. With regard to tumor location, RPT has better pathological outcomes and oncological prognoses than UT.PMID:37634073
Source: Urology Journal - August 27, 2023 Category: Urology & Nephrology Authors: Yuki Kohada Tetsutaro Hayashi Kenshiro Takemoto Syunsuke Miyamoto Takashi Babasaki Kohei Kobatake Hiroyuki Kitano Kenichiro Ikeda Keisuke Goto Keisuke Hieda Yukiko Honda Kazuhiro Sentani Naohide Oue Kazuo Awai Nobuyuki Hinata Source Type: research
Impact of warm saline irrigation, hyperthermic intraperitoneal chemotherapy on postoperative pain in primary ovarian cancer from the KOV-HIPEC-01 randomized trial
CONCLUSION: The addition of HIPEC to cytoreductive surgery did not lead to increased postoperative pain, as demonstrated by a reduction in the use of analgesics and lower scores on postoperative pain scales during the early postoperative period.PMID:37634257 | DOI:10.1016/j.ygyno.2023.08.006
Source: Gynecologic Oncology - August 27, 2023 Category: Cancer & Oncology Authors: Ji Hyun Kim Kyung Nam Park Eun Young Park Min Jung Jang Yoen Jung Park Youseok Kim Suk-Joon Chang Sang-Yoon Park Jung Yeon Yun Myong Cheol Lim Source Type: research
The Efficacy of Neoadjuvant Gemcitabine and Cisplatin Chemotherapy for cT3N0M0 Upper Tract Urothelial Carcinoma: The Impact of Tumor Location
CONCLUSION: NAC-GC improves both pathological outcomes and oncological prognosis in patients with cT3N0M0 UTUC. With regard to tumor location, RPT has better pathological outcomes and oncological prognoses than UT.PMID:37634073
Source: Urology Journal - August 27, 2023 Category: Urology & Nephrology Authors: Yuki Kohada Tetsutaro Hayashi Kenshiro Takemoto Syunsuke Miyamoto Takashi Babasaki Kohei Kobatake Hiroyuki Kitano Kenichiro Ikeda Keisuke Goto Keisuke Hieda Yukiko Honda Kazuhiro Sentani Naohide Oue Kazuo Awai Nobuyuki Hinata Source Type: research
